残余肾功能与透析充分性对透析患者慢性瘙痒的影响
研究纳入荷兰NECOSAD研究中1256例起始血液透析和670例腹膜透析患者(1997-2007年),随访至死亡、移植或最长10年,采用KDQOL-36单条目测量CKD相关瘙痒。多变量调整后发现,透析开始12个月时较高的残余eGFR和较低的血清磷酸盐水平与较低的CKD相关瘙痒负担相关,而透析Kt/V与瘙痒无关。
要点
- 在血液透析和腹膜透析患者中,残余eGFR每升高1 mL/min/1.73 m2与CKD相关瘙痒负担降低相关。
- 血清磷酸盐每降低1 mmol/L与较低的CKD相关瘙痒负担相关。
- 透析Kt/V与CKD相关瘙痒之间未发现关联。
核心结论
- 较高的残余eGFR和较低的血清磷酸盐水平,而非透析剂量,与透析患者较低的CKD相关瘙痒负担相关。
研究设计与样本
- 研究纳入荷兰透析充分性合作研究(NECOSAD)中1256例起始血液透析和670例腹膜透析患者(>18岁),纳入时间为1997-2007年,随访至死亡、移植或最长10年。
- CKD相关瘙痒采用肾脏疾病生活质量量表-36(KDQOL-36)的单一条目测量。
- 采用逻辑回归和线性回归分析,并调整基线潜在混杂因素。
主要发现
- 基线平均(标准差)年龄为60(16)岁,62%为男性,残余eGFR中位数(四分位距)为3.4(1.7; 5.3)mL/min/1.73 m2。
- CKD相关瘙痒患病率(约70%)在血液透析和腹膜透析中相似。
- 透析开始12个月后(多变量调整后),残余eGFR每升高1 mL/min/1.73 m2,血液透析和腹膜透析患者的CKD相关瘙痒负担分别降低-0.05(95% CI -0.09; -0.02)和-0.09(95% CI -0.13; -0.05)。
- 每周总Kt/V每升高1个单位,血液透析和腹膜透析患者的CKD相关瘙痒负担分别降低-0.15(95% CI -0.26; -0.05)和-0.35(95% CI -0.54; -0.16)。
- 血清磷酸盐每降低1 mmol/L,血液透析和腹膜透析患者的CKD相关瘙痒负担分别降低-0.34(95% CI -0.51; -0.17)和-0.45(95% CI -0.71; -0.19)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease-associated pruritus (CKD-aP) is common in dialysis patients, and is associated with lower quality of life and increased risk of death. We investigated the association between residual estimated glomerular filtration rate (eGFR), dialysis adequacy or serum phosphate level and CKD-aP in incident dialysis patients. METHODS: A total of 1256 incident hemodialysis (HD) and 670 peritoneal dialysis (PD) patients (>18 years) from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) study were included (1997-2007) and followed until death, transplantation or a maximum of 10 years. CKD-aP was measured using a single item of the Kidney Disease Quality of Life Instrument-36. The associations were studied by logistic and linear regression analyses, adjusted for potential baseline confounders. RESULTS: At baseline mean (standard deviation) age was 60 (16) years, 62% were men and median (interquartile range) residual eGFR was 3.4 (1.7; 5.3) mL/min/1.73 m2. The prevalence of CKD-aP (∼70%) was similar in HD and PD. It was observed that 12 months after starting dialysis (after multivariable adjustment) each 1 mL/min/1.73 m2 higher residual eGFR, one unit higher total weekly Kt/V, or 1 mmol/L lower serum phosphate level was associated with lower burden of CKD-aP in HD and PD patients of -0.05 (95% CI -0.09; -0.02) and -0.09 (95% CI -0.13; -0.05), -0.15 (95% CI -0.26; -0.05) and -0.35 (95% CI -0.54; -0.16), and of -0.34 (95%CI: -0.51; -0.17) and -0.45 (95%CI: -0.71; -0.19), respectively. We found no association between dialysis Kt/V and CKD-aP. CONCLUSIONS: Higher residual eGFR and lower serum phosphate level, but not the dialysis dose, were related with lower burden of CKD-aP in dialysis patients.
引用
- Lengton R, van der Willik EM, de Rooij ENM, et al. Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients. Nephrol Dial Transplant. 2023. PMID: 36549655. doi:10.1093/ndt/gfac341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。